# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 134

Extent: E+W+S+N.I.

In regulation 167 (insertion of regulation 205A (further obligations in respect of pharmacovigilance activities)), in the inserted regulation 205A—
(a) in paragraph (1), after “Schedule 12A” insert “ applies in relation to medicinal products for sale or supply under a UKMA(GB) or THR(GB) and ”;
(b) in paragraph (2)—
(i) for “The Ministers” substitute “ The Secretary of State ”;
(ii) after “by regulations” insert “ in respect of Great Britain ”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/134 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-134
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.